Literature DB >> 16431095

A comparison of exhaled nitric oxide measurements performed using three different analysers.

Zoë Borrill1, David Clough, Nick Truman, Julie Morris, Stephen Langley, Dave Singh.   

Abstract

INTRODUCTION: Exhaled nitric oxide (NO) is an established technique for monitoring airway inflammation. We have compared exhaled NO measurements from 3 different analysers; Ecomedics (E), Niox (N) and Logan (L).
METHODS: Thirty subjects (10 non-smoking healthy subjects, 10 non-smoking patients with asthma and 10 ex-smoking COPD patients) performed 3 repeated measurements of exhaled NO at a flow rate of 50 ml/s on each of the 3 analysers. Within analyser variability was determined by calculating the repeatability coefficient for each analyser. Differences between analysers were assessed by (1) the differences between group means and (2) the Bland Altman method to estimate the variability expected for an individual using the 3 analysers.
RESULTS: The repeatability coefficients (expressed as ratios) were 1.12, 1.19 and 1.19 for N, E and L, respectively. There were significant differences (P<0.05) between analysers; the Logan analyser gave the highest group mean values and Ecomedics gave the lowest group mean values. Differences between analysers were observed in all subject groups (healthy, asthma, COPD). Similar results were obtained in the 3 groups when analysed separately. Bland Altman analysis gave the following ratios [data are mean ratio (95% limits of agreement)]; N:E 1.59 (1.02-2.50), L:N 1.23 (0.72-2.13), L:E 1.96 (1.09-3.57).
CONCLUSION: Our findings indicate that exhaled NO measurements in healthy subjects and patients with airways disease differ according to the type of analyser used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431095     DOI: 10.1016/j.rmed.2005.11.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 2.  Predictive Biomarkers for Asthma Therapy.

Authors:  Sarah K Medrek; Amit D Parulekar; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-19       Impact factor: 4.806

3.  Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.

Authors:  Stephanie Korn; Maike Wilk; Stefanie Voigt; Stephan Weber; Thomas Keller; Roland Buhl
Journal:  Respiration       Date:  2019-07-09       Impact factor: 3.580

4.  Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study.

Authors:  J Choi; L A Hoffman; J M Sethi; T G Zullo; K F Gibson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

Review 5.  Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications.

Authors:  Jaime Mirowsky; Terry Gordon
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-21       Impact factor: 5.563

Review 6.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

7.  Reference values for exhaled nitric oxide (reveno) study.

Authors:  Mario Olivieri; Giorgio Talamini; Massimo Corradi; Luigi Perbellini; Antonio Mutti; Claudio Tantucci; Mario Malerba
Journal:  Respir Res       Date:  2006-06-30

8.  Bronchial responsiveness is related to increased exhaled NO (FE(NO)) in non-smokers and decreased FE(NO) in smokers.

Authors:  Andrei Malinovschi; Christer Janson; Marieann Högman; Giovanni Rolla; Kjell Torén; Dan Norbäck; Anna-Carin Olin
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  COPD phenotype description using principal components analysis.

Authors:  Kay Roy; Jacky Smith; Umme Kolsum; Zöe Borrill; Jørgen Vestbo; Dave Singh
Journal:  Respir Res       Date:  2009-05-29

10.  Exhaled nitric oxide in a population-based study of southern California schoolchildren.

Authors:  William S Linn; Edward B Rappaport; Kiros T Berhane; Tracy M Bastain; Edward L Avol; Frank D Gilliland
Journal:  Respir Res       Date:  2009-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.